Background: Pulmonary embolism (PE) with cor pulmonale causes considerable mortality and morbidity. Randomized trials have failed to show a mortality difference between treatment modalities including anticoagulation (AC), Catheter directed thrombolysis (CDT) and systemic tPA (tissue plasminogen activator).
Methods: This is a cross-sectional retrospective case-control study utilizing the 2017 National Inpatient Sample (NIS).